You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 1
  • 1ISG-007 HTA analysis for the inclusion of Andexanet Alfa (AA) within the Hospital Therapeutic Handbook (HTH) – the experience of an Italian centre specialising in cardiovascular diseases

Article info

Article menu

Download PDFPDF

Section 1: Introductory statements and governance
1ISG-007 HTA analysis for the inclusion of Andexanet Alfa (AA) within the Hospital Therapeutic Handbook (HTH) – the experience of an Italian centre specialising in cardiovascular diseases
Free

Authors

Citation

Zitelli S, Iezzi A, Teso V, et al
1ISG-007 HTA analysis for the inclusion of Andexanet Alfa (AA) within the Hospital Therapeutic Handbook (HTH) – the experience of an Italian centre specialising in cardiovascular diseases
European Journal of Hospital Pharmacy 2024;31:A9.

Publication history

  • First published March 20, 2024.
Online issue publication 
March 20, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ.